Karine Lignel

Karine Lignel is a declared insider at 2 companies (board member); the most frequent names are Oncodesign and Oncodesign Precision Medicine S.A. Between 28 April 2022 and 12 December 2022, the trades on record add up to 6 filings.

In open-market terms, that means 5 purchases worth €702k on one side and 1 sale worth €400k on the other. On balance, insiders were net buyers of €303k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

Half of the purchases are above €164k and half below. 2 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 19 December 2022, reports an open-market purchase of €164k in Oncodesign Precision Medicine S.A. The median gap between a trade and its publication by AMF is 6 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.